Depression and cardiovascular disease progression: Epidemiology, mechanisms and treatment

Petra Hoen; Nina Kupper; Peter De Jonge

doi:10.1007/978-1-84882-419-5_12

Depression and cardiovascular disease progression: Epidemiology, mechanisms and treatment

Petra Hoen^*, Nina Kupper, Peter De Jonge

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

3 Citations (Scopus)

Abstract

Depression and coronary heart disease (CHD) are the two strongest contributors to the global burden of disease.¹ Both disorders are common, and while cardiovascular disease is an important factor directly contributing to mortality, depression is primarily associated with decreased health-related quality of life,² and imposes a significant economic burden on society.³ However, there are also signs that depression may contribute to higher mortality rates, perhaps due to its association with somatic disease, and in particular CHD.

Original language	English
Title of host publication	Stress and Cardiovascular Disease
Publisher	Springer-Verlag London Ltd
Pages	211-233
Number of pages	23
Volume	9781848824195
ISBN (Electronic)	9781848824195
ISBN (Print)	1848824181, 9781848824188
DOIs	https://doi.org/10.1007/978-1-84882-419-5_12
Publication status	Published - 1-Nov-2012

Keywords

Cardiovascular disease progression
Depression
Epidemiology
Inflammation
Mechanisms
Platelet function
Screening
Serotonin metabolism
Treatment

Access to Document

10.1007/978-1-84882-419-5_12

Handle.net

Persistent link

Cite this

@inbook{2ebb425a03fa4be5a4efe8770bcef0fe,

title = "Depression and cardiovascular disease progression: Epidemiology, mechanisms and treatment",

abstract = "Depression and coronary heart disease (CHD) are the two strongest contributors to the global burden of disease.1 Both disorders are common, and while cardiovascular disease is an important factor directly contributing to mortality, depression is primarily associated with decreased health-related quality of life,2 and imposes a significant economic burden on society.3 However, there are also signs that depression may contribute to higher mortality rates, perhaps due to its association with somatic disease, and in particular CHD.",

keywords = "Cardiovascular disease progression, Depression, Epidemiology, Inflammation, Mechanisms, Platelet function, Screening, Serotonin metabolism, Treatment",

author = "Petra Hoen and Nina Kupper and {De Jonge}, Peter",

note = "Publisher Copyright: {\textcopyright} 2012 Springer-Verlag London Limited.",

year = "2012",

month = nov,

day = "1",

doi = "10.1007/978-1-84882-419-5_12",

language = "English",

isbn = "1848824181",

volume = "9781848824195",

pages = "211--233",

booktitle = "Stress and Cardiovascular Disease",

publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Depression and cardiovascular disease progression

T2 - Epidemiology, mechanisms and treatment

AU - Hoen, Petra

AU - Kupper, Nina

AU - De Jonge, Peter

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Depression and coronary heart disease (CHD) are the two strongest contributors to the global burden of disease.1 Both disorders are common, and while cardiovascular disease is an important factor directly contributing to mortality, depression is primarily associated with decreased health-related quality of life,2 and imposes a significant economic burden on society.3 However, there are also signs that depression may contribute to higher mortality rates, perhaps due to its association with somatic disease, and in particular CHD.

AB - Depression and coronary heart disease (CHD) are the two strongest contributors to the global burden of disease.1 Both disorders are common, and while cardiovascular disease is an important factor directly contributing to mortality, depression is primarily associated with decreased health-related quality of life,2 and imposes a significant economic burden on society.3 However, there are also signs that depression may contribute to higher mortality rates, perhaps due to its association with somatic disease, and in particular CHD.

KW - Cardiovascular disease progression

KW - Depression

KW - Epidemiology

KW - Inflammation

KW - Mechanisms

KW - Platelet function

KW - Screening

KW - Serotonin metabolism

KW - Treatment

U2 - 10.1007/978-1-84882-419-5_12

DO - 10.1007/978-1-84882-419-5_12

M3 - Chapter

AN - SCOPUS:84929862748

SN - 1848824181

SN - 9781848824188

VL - 9781848824195

SP - 211

EP - 233

BT - Stress and Cardiovascular Disease

PB - Springer-Verlag London Ltd

ER -

Depression and cardiovascular disease progression: Epidemiology, mechanisms and treatment

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this